Skip to content

Pulmonx Corporation LUNG Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$13.65M+5.5%-$10.43M+20.9%-$13.96M+1.3%-$15.17M+1.0%-$14.45M-5.1%
$220K-20.9%$231K-21.4%$246K-34.6%$299K-25.3%$278K-34.3%
$4.14M-26.3%$4.24M-23.2%$5.17M-11.5%$6.21M+5.0%$5.61M-1.1%
-$4K$0-100%
$46K+318%$15K+36.4%$14K+27.3%$13K-7.1%$11K-31.3%
-$1.2M-267%-$1.61M-192%-$1.41M$1.22M$721K+153%
$959K+336%$810K+429%$1.02M-$660K-$406K-137%
-$430K-185%$121K-91.0%$2.14M$505K-69.1%
-$1.17M+76.2%-$443K-111%-$4.89M+18.2%
-$61K-117%$369K+1,519%
$14K+275%-$73K-352%-$53K-$8K-200%
$51K+113%$109K+706%$0$68K$24K+209%
$415K+15.3%$368K+10.5%$465K+55.0%$255K-50.0%$360K-48.6%
-$107K$0
-$329K-789%-$281K-$381K+16.4%-$256K+60.7%-$37K+95.6%
-$10.1M+23.6%-$7.08M-5.3%-$8.16M-12.7%-$3.91M+32.3%-$13.22M-12.1%
$9K-97.0%$13K-88.3%$89K-78.6%$49K-89.6%$301K-33.3%
$0-100%$1.73M-75.4%$3.92M-71.6%
$0-100%$0-100%$8.8M-31.0%$7.25M+8.8%$20.54M+74.8%
-$9K-100%$0-100%$8.71M+29.0%$5.47M+755%$16.31M+751%
$38.79M$0
$37M$51K+4.1%$1K$48K$0
$40K-63.6%$106K-3.6%$5K-82.1%$28K+16.7%$110K+96.4%
$2.03M+205%$55K-11.3%$181K-60.6%$0$664K-23.1%
-$100K+4.8%-$583K-$105K-319%
-$8.18M-324%-$6.8M$1.09M+819%$913K+114%$3.65M+127%
$789K+0.1%$749K-8.8%$792K-10.3%$784K-13.2%$788K-9.9%
$76K-30.3%$104K+9.5%$150K-18.9%$105K-0.9%$109K-35.9%
$0-100%$0-100%$40K-90.1%$133K-72.2%$206K-47.6%
$46K+318%$15K+36.4%$14K+27.3%$13K-7.1%$11K-31.3%
-$4K$0-100%
-$329K-789%-$281K-$381K+16.4%-$256K+60.7%-$37K+95.6%
$29K+109%-$627K-564%-$791K-122%-$308K-15.8%
$144K+413%$167K$72K-$50K-141%-$46K-128%
$415K+15.3%$368K+10.5%$465K+55.0%$255K-50.0%$360K-48.6%
$220K-20.9%$231K-21.4%$246K-34.6%$299K-25.3%$278K-34.3%
$67K$0
$0-100%$0-100%$8.8M-31.0%$7.25M+8.8%$20.54M+74.8%
$38.79M$0
$201K-63.7%$200K-53.6%$554K-31.4%
$37M$0
$0-100%$66K-4.3%$9K-91.0%
$400K$0
$14K+275%-$73K-352%-$53K-$8K-200%
-$329K-789%-$281K-$381K+16.4%-$256K+60.7%-$37K+95.6%
$1.38M$0
$76K-30.3%$104K+9.5%$150K-18.9%$105K-0.9%$109K-35.9%
-$10.11M+25.3%-$7.1M-3.7%-$8.25M-7.7%-$3.96M+36.6%-$13.52M-10.4%
-$10.11M+25.3%-$7.1M-3.7%-$8.25M-7.7%-$3.96M+36.6%-$13.52M-10.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pulmonx Corporation generate?
Pulmonx Corporation (LUNG) generated -$29.3M in operating cash flow over the trailing twelve months.
What is Pulmonx Corporation's free cash flow?
After $160.0K of capital expenditures, Pulmonx Corporation's free cash flow was -$29.4M over the trailing twelve months, up 14.2% year over year.
Where does Pulmonx Corporation's cash flow data come from?
Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.